MONTE ROSA THERAPEUTIC
5.0000
08-October-24 15:59:57
15 minutes delayed
Stocks
-0.0700
-1.38%
Today's range
4.9500 - 5.1900
ISIN
N/A
Source
NASDAQ
-
06 Sep 2022 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates
11 Aug 2022 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results and Business Updates
11 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
08 Apr 2022 13:00:00 By Nasdaq GlobeNewswire
-
29 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences
03 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
02 Dec 2021 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
22 Nov 2021 07:30:00 By Nasdaq GlobeNewswire
-
10 Nov 2021 07:30:01 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Present at 4th Annual Targeted Protein Degradation Summit
20 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
07 Oct 2021 09:00:02 By Nasdaq GlobeNewswire
-
30 Sep 2021 16:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® Indexes
10 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference
08 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
12 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Monte Rosa Therapeutics Announces Pricing of Initial Public Offering
23 Jun 2021 20:20:00 By Nasdaq GlobeNewswire